Indicated for: diabetic ulcers
Route of administration: cutaneous
Substance: becaplermine (wound-healing agent)
ATC: D03AX06 (Dermatologicals | Cicatrizants | Other cicatrizants)
Becaplermin is a platelet-derived growth factor used in the treatment of chronic wounds, such as diabetic foot ulcers. It works by stimulating cellular proliferation and angiogenesis, accelerating the healing process of affected tissues.
Becaplermin is applied topically as a gel directly to the cleaned wound, as directed by a physician. The treatment is usually combined with other wound care measures, such as debridement and infection control, to maximize effectiveness.
Common side effects include local irritation, erythema, and pruritus at the application site. In rare cases, prolonged use may increase the risk of cutaneous neoplasms. It is important for patients to strictly follow medical instructions and monitor the healing progress.
Becaplermin is a valuable therapeutic option for managing chronic wounds, contributing to improved quality of life and reducing the risk of complications.